Coronary Primary Prevention Trial PDF Download

Author:
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2

View

Book Description

Author: Paul Durrington
Publisher: CRC Press
ISBN: 0340807814
Category : Medical
Languages : en
Pages : 429

View

Book Description
The third edition of this well-received text provides a state-of-the-art treatise on modern clinical practice relating to hyperlipidaemia and lipoprotein disorders, conditions responsible for a huge amount of morbidity and mortality in Western countries and, increasingly, the developing world. The clinical evidence underlying the treatment of hyperlipidaemia has burgeoned since the second edition published in 1994, with the publication of the results of several clinical trials on statin drugs, and the subsequent appearance of national and international guidelines for cholesterol lowering in coronary prevention. There has also been considerable development in the definition of cardiovascular risk, and the methodology for identifying high-risk patients. All of these aspects are addressed fully in the new edition. In addition, the book offers helpful summaries of the background biochemistry of lipoprotein metabolism and atherosclerosis where relevant, putting the subject in the context of its pathophysiology and epidemiology. The text relating to clinical aspects has a strong evidence base, reviewing, in particular, areas of uncertainty and controversy. Drawing on the wealth of experience of the author, and representing his widely respected views on the subject, readers will find this comprehensive, well-referenced and accessible book invaluable.

Author: M. Godfrey
Publisher: Springer Science & Business Media
ISBN: 9401138982
Category : Medical
Languages : en
Pages : 110

View

Book Description
1 Shepherd Coronary artery disease, the most important cause of death in the United Kingdom, kills about 200 000 Britons each year. Many victims are struck down out of the blue and in the prime of an active working life. Others survive the fIrst attack but are so debilitated by it that they are compelled to fall back on the efforts of their family and the Social and Health Services for their future survival. The epidemic proportions of the problem and the burden which it places on the community at large has led many health care professionals to reassess their attitudes to heart disease prevention. In the past, the clinician's attention has been directed primarily at the treatment of established ischaemic heart disease rather than focussing on forestalling its appearance by attempting to tackle those life-style habits within the population which appear to predispose to it. A number of recent developments make this approach hard to sustain. First, there is now convincing evidence that action taken against cigarette smoking, hyper tension and hypercholesterolaemia offers signifIcant protection to the individual. Secondly, effective and apparently safe antihypertensive and lipid-lowering agents have recently become available to the practicing clinician. Thirdly, developments in computer technology and laboratory equipment manufacture have brought the measurement of coronary risk factors right into the primary health care setting. And, last, but not least, political attitudes towards prevention now favour the enthusiastic general practitioner with an interest in anticipating and averting the development of degenerative diseases like atherosclerosis.

Author: Wilbert S. Aronow
Publisher: BoD – Books on Demand
ISBN: 1839685077
Category : Medical
Languages : en
Pages : 176

View

Book Description
Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.

Author: Paul N. Durrington
Publisher: Wright Publishing Company
ISBN:
Category : Medical
Languages : en
Pages : 332

View

Book Description

Author: A. Stewart Truswell
Publisher: Springer Science & Business Media
ISBN: 904818875X
Category : Medical
Languages : en
Pages : 228

View

Book Description
“Only once in a great while does a book come along that really does the job in addressing a major medical issue. When this happens, all can be joyful... Readers will find ALL their favorite dietary puzzlements dealt with... With consummate scholarship, clarity and brevity, Truswell sifts out the chaff and identifies the critical questions, the responsible investigators, and the key studies.” So says Emeritus Professor Henry Blackburn from the University of Minnesota in the foreword to this remarkable concise book on the history of research on diet and heart disease. This was a theme of scientific, medical and public interest in the 20th Century, a century marked by the rise and fall of coronary heart disease as the major cause of death in the first world, followed by the rise of this cause of death in the developing world. There is obviously much to learn, and this book is an excellent starting point, tracing dietary factors and their role in heart disease one by one: fats, sugar, salt, alcohol, coffee, trans-fats, etc. Without an understanding of the role of diet and the changes that have been seen in the North American and NW European diet, the story of the decline in the heart disease death rate may have been very different.

Author: Hussein Yassine
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268

View

Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.

Author: Judith Mackay
Publisher: World Health Organization
ISBN: 9789241562768
Category : Medical
Languages : en
Pages : 118

View

Book Description
Heart disease and strokes are currently the leading cause of death in all developed countries and in most developing countries, resulting in one third of all deaths globally in 2003. This publication explores a range of issues relating to this increasingly urgent global health problem using text, colour charts, maps and graphics. Topics covered include: different types of cardiovascular diseases, including rheumatic heart disease; key risk factors including smoking, obesity, physical inactivity, high cholesterol levels and diabetes; risks factors relating to women, childhood and youth; the global burden of coronary heart disease and stroke, and associated economic costs; medical research and funding issues; prevention in personal and public health terms; treatment options; health education; national policies and legislation to address prevention and control; future predictions; chronology of key developments in knowledge of cardiovascular disease; and world data tables.

Author: Paul D. Thompson
Publisher: Springer Nature
ISBN: 3030333043
Category : Medical
Languages : en
Pages : 191

View

Book Description
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.

Author: Paul N Durrington
Publisher: CRC Press
ISBN:
Category : Medical
Languages : en
Pages : 428

View

Book Description
The second edition of Hyperlipidaemia: Diagnosis and Management is thoroughly updated and provides a comprehensive account of the clinical and therapeutic aspects of the subject in the context of its pathophysiology and epidemiology. The biochemistry of lipoprotein metabolism and atherosclerosis is reviewed before focussing on the clinical aspects of the disorders and thoroughly discussing the epidemiological and clinical trial evidence for therapeutic benefit and the various international recommendations for treatment. Durrington draws on a wide breadth of clinical experience and very up-to-date information. All recent developments in the genetics of hyperlipidaemia, in secondary hyperlipidaemias and in nutritional and pharmacological therapy are discussed, as are the laboratory services required to support a lipid clinic.